| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000535 | EBV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30079906 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30083071 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1H |
|---|---|
| DrugBank ID | DB06712 |
| Drug Name | Nilvadipine |
| Target ID | BE0000864 |
| UniProt ID | O95180 |
| Regulation Type | inhibitor |
| PubMed IDs | 19401195 |
| Citations | Furukawa T, Nukada T, Namiki Y, Miyashita Y, Hatsuno K, Ueno Y, Yamakawa T, Isshiki T: Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes. Eur J Pharmacol. 2009 Jun 24;613(1-3):100-7. doi: 10.1016/j.ejphar.2009.04.036. Epub 2009 May 3. |
| Groups | Approved; Investigational |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N |
| Pathways | |
| PharmGKB | PA165958385 |
| ChEMBL | CHEMBL517427 |
